Definition of a fully vaccinated individual:
A person is considered to be fully vaccinated 2 weeks after receiving the final recommended vaccine dose(s) of a WHO-approved vaccine or vaccine combination as indicated below.
On Thursday 16th December, 2021, the World Health Organization (WHO) released updated guidelines on COVID-19 vaccination, which indicate that any of the COVID-19 vaccines which have received a WHO Emergency Use Listing (EUL) may be used interchangeably.
Thus means that persons who received 2 doses of any combination of WHO approved COVID-19 vaccines with a 2-dose regimen will now be considered fully vaccinated two weeks after receipt of the final dose. Persons who received a single dose of a Johnson & Johnson vaccine will continue to be considered fully vaccinated two weeks after receipt of the vaccine.
The following COVID-19 Vaccines have received WHO EUL approval:
- Pfizer-BioNTech - Approved 31st December 2020
- AstraZeneca - Approved 15th February 2021
- Janssen (Johnson and Johnson) - Approved 12th March 2021
- Moderna-NIAID - Approved 30th April 2021
- Sinopharm BIBP- Approved 7th May 2021
- Sinovac-CoronaVac - Approved 1st June 2021
- Covaxin BBV152 – Approved 3rd November, 2021
- Covovax - Approved 17th December, 2021
- Novavax - NVX-CoV2373/Nuvaxovid - Approved 20th December, 2021